An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India
Recruiting
- Conditions
- Contrast Enhancement in Magnetic Resonance Imaging
- Registration Number
- NCT06257277
- Lead Sponsor
- Bayer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Inclusion Criteria:<br><br> - GBCA-naïve male/female patients of at least 18 years of age.<br><br> - willing to participate in the active surveillance and agree to be contacted by phone<br> after 6 (±2) weeks after the MR scan for brief interviews.<br><br>Exclusion Criteria:<br><br> - None.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of adverse events reported after use of branded gadolinium-based contrast agent (GBCA).;Number for participants with adverse events after use of a branded GBCA
- Secondary Outcome Measures
Name Time Method